Patents by Inventor Mitsuyo Kondo

Mitsuyo Kondo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS
    Publication number: 20170114044
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on. A compound of formula (I0) wherein R1 represents a substituent, R2 represents a hydrogen atom, or a substituent, R3 represents a hydrogen atom, or a substituent, Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
    Type: Application
    Filed: December 13, 2016
    Publication date: April 27, 2017
    Inventors: Takahiko TANIGUCHI, Akira KAWADA, Mitsuyo KONDO, John F. QUINN, Jun KUNITOMO, Masato YOSHIKAWA, Makoto FUSHIMI
  • PYRIDAZINONE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS AND METHODS OF TREATING DISORDERS
    Publication number: 20150099757
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on. A compound of formula (I0): wherein R1 represents a substituent, R2 represents a hydrogen atom, or a substituent, R3 represents a hydrogen atom, or a substituent, Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 9, 2015
    Inventors: Takahiko TANIGUCHI, Akira KAWADA, Mitsuyo KONDO, John F. QUINN, Jun KUNITOMO, Masato YOSHIKAWA, Makoto FUSHIMI
  • PYRIDAZINONE COMPOUNDS
    Publication number: 20120277204
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on. A compound of formula (I0), wherein R1 represents a substituent; R2 represents a hydrogen atom, or a substituent; R3 represents a hydrogen atom, or a substituent; Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
    Type: Application
    Filed: July 6, 2012
    Publication date: November 1, 2012
    Inventors: Takahiko TANIGUCHI, Akira Kawada, Mitsuyo Kondo, John F. Quinn, Jun Kunitomo, Masato Yoshikawa, Makoto Fushimi
  • PYRIDAZINONE COMPOUNDS
    Publication number: 20120028951
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on. A compound of formula (I0), wherein R1 represents a substituent; R2 represents a hydrogen atom, or a substituent; R3 represents a hydrogen atom, or a substituent; Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
    Type: Application
    Filed: February 4, 2010
    Publication date: February 2, 2012
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Takahiko Taniguchi, Akira Kawada, Mitsuyo Kondo, John F. Quinn, Jun Kunitomo, Masato Yoshikawa, Makoto Fushimi
  • Pyridazinone compounds
    Publication number: 20100197651
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as a medicament for preventing or treating schizophrenia or so on. A compound of formula (I0): wherein R1 represents a substituent, R2 represents a hydrogen atom, or a substituent, R3 represents a hydrogen atom, or a substituent, Ring A represents an aromatic ring which can be substituted, and Ring B represents a 5-membered heteroaromatic ring which can be substituted, or a salt thereof.
    Type: Application
    Filed: February 4, 2010
    Publication date: August 5, 2010
    Inventors: Takahiko Taniguchi, Akira Kawada, Mitsuyo Kondo, John F. Quinn, Jun Kunitomo, Masato Yoshikawa, Makoto Fushimi
  • Process for producing recombinant protein
    Publication number: 20050209447
    Abstract: It is intended to produce a target protein in procaryotic or eucaryotic cells. A DNA encoding the full-length amino acid sequence or a part of the same of a target protein is prepared and the target protein is produced by a gene recombination technique with the use of this DNA.
    Type: Application
    Filed: July 25, 2001
    Publication date: September 22, 2005
    Inventors: Takashi Ito, Yoko Tanaka, Mitsuyo Kondo
  • Betacellulin modification
    Patent number: 6825165
    Abstract: The betacellulin mutein or its salt of the present invention is useful for better therapeutic drug for diabetes. Since they have intact BTC activity and reduced EGF activity, and no antigenicity-related problems.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: November 30, 2004
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Takashi Ito, Mitsuyo Kondo, Yoko Tanaka, Masayuki Kobayashi, Koichi Igarashi, Reiko Sasada, Osamu Nishimura